Recent Headlines
Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS
The ALS Research Collaborative will revolutionize ALS research by providing scientists with unprecedented access to the data and tools they need to discover new treatments and accelerate progress toward cures for ALS. - March 15, 2023 - ALS Therapy Development Institute
New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China
Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC
New York Imaging Specialists Names Dr. Matthew Comito Chief Radiology Officer
New York Imaging Specialists is proud to announce that radiologist Matthew Comito, MD, has been appointed Chief Radiology Officer. “Dr. Comito has the administrative, scientific, clinical, leadership, and visionary skills needed to move the Department of Radiology forward,” said Jeff... - February 16, 2023 - New York Imaging Specialists
Santa Fe BioLabs Develops Optimized and Selective Media for the Pathogenic Yeast Candida auris and is Awarded Wide-Ranging Patent for Design of Selective Microbial Media
Santa Fe BioLabs concluded development of ReCand, a medium for optimized colony formation of dry Candida auris, and AuriFind, a medium for identification by selective growth of viable Candida auris. A patent has been granted for media development based on the underlying principle of modulation of toxicity by quaternary ammonium compounds. - February 16, 2023 - Santa Fe BioLabs LLC
Ocean View Primary Care Wins Hearts in Delmarva
Ocean View Primary Care provides services such as adult primary care, pediatrics, preventative care, immunization, nutrition counseling and laboratory testing. In collaboration with Cardiac Medical Services, Inc. it also utilizes the latest advancements in cardiac technology to evaluate and assess a patient's cardiac health. The open-access practice model allows for same-day appointments for acute and same-day after-hours calls for all types of care. - February 08, 2023 - Cardiac Medical Services, Inc.
DistillerSR Launches Industry's Most Comprehensive and Configurable PRISMA 2020 Flow Diagram Reporting Module
DistillerSR® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today announced the launch of full support for the PRISMA 2020 report guidelines. DistillerSR’s PRISMA 2020 flow diagram reporting module enables research... - January 31, 2023 - DistillerSR
Zifo R&D Solutions Announces Acquisition of beyontics GmbH
Zifo, a leading global specialist scientific informatics services provider, announces the acquisition of beyontics™. A scientific service provider, beyontics has extensive experience in selecting, configuring, optimizing, and supporting Chromatography Data Systems (CDS), particularly the... - January 19, 2023 - Zifo
Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community
Partnership Will Expand to Include Educational and Donation Event with OneBlood. - January 17, 2023 - Hemanext
Virb Lands New Contract; Expands Its Offerings to Asias with $10B Life Science Company
Virb has grown outside the US, now servicing contracts in India and Japan with new client. - January 11, 2023 - Virb
End the Legacy, Dedicated to Providing Resources to and Advocating for the Genetic ALS and FTD Community, Presenting to FDA January 12
Individuals impacted by hereditary ALS and FTD announce the establishment of a nonprofit organization dedicated to supporting and advocating for their community, Genetic ALS & FTD: End the Legacy. ALS and FTD are neurodegenerative diseases. ALS affects the motor system and leads to rapidly... - January 10, 2023 - Genetic ALS & FTD: End the Legacy
Huntington Study Group Names First Chief Innovation Officer
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, today announced Brett Kinsler has been named to the newly created position of Chief Innovation Officer (CINO). - January 10, 2023 - Huntington Study Group
Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”
With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy
Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”
Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and capabilities (this division is now referred to as Paras Biopharma), the creation of Paras Biologics enhances the company’s biologics and biosimilar pipeline for co-development and licensing opportunities. - December 11, 2022 - Paras Biopharmaceuticals Finland Oy
Brooke Spicer Joins Sureguard LLC as Director of Operations
The industry disrupting laboratory services company continues expansion to improve the experience of long-term care facilities. - December 08, 2022 - Sureguard LLC
Clinical Research Organization, Huntington Study Group “Firsts” Continue
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) through its Clinical Research Organization (CRO), HSG Clinical Research, Inc. (HSGCR) continues making groundbreaking progress in the HD world. At their Annual Meeting in November, the... - December 05, 2022 - Huntington Study Group
Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company
Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy
Huntington Study Group Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD), recently held its 29th Annual Meeting in Tampa, FL. This renowned meeting brings together HD thought leaders, scientific experts, industry partners and sponsors, advocacy groups, and... - November 29, 2022 - Huntington Study Group
Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility
The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen
Pregmune Joins Digital Twin Consortium
Pregmune is thrilled to announce that has recently joined the Digital Twin Consortium (DTC), a global initiative created with the goal to be The Authority in Digital Twin(TM) as it relates to policy, security, interoperability, and overall development of digital twins. Founded in 2020 by Dr. - November 17, 2022 - Pregmune
Virb Lands Contract with $10B Life Sciences Company
Begins Series A Financing to Accelerate Growth in the Clinical Research Industry. - November 16, 2022 - Virb
DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments
DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint
New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings
GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.
DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research
CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR
Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce the results from the novel HD-Net survey, which examined the United States Huntington’s disease (HD) care delivery in a variety of clinic settings by HD specialists and non-specialists. - October 25, 2022 - Huntington Study Group
Minus K Technology Announces Announces Its Seventh U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities
As Minus K celebrates their upcoming 30 years in business, they are giving away $25,000* dollars worth of passive mechanical patented superior performing negative-stiffness low-frequency vibration isolators to colleges in the United States. - October 25, 2022 - Minus K Technology Inc.
Huntington Study Group Announces myHDstory™ Pilot Study: Making HD Voices Heard Has Reached Target Enrollment
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce that the pilot study, Making HD Voices Heard, on the new online research platform, myHDstory™, has reached its enrollment target. “The HSG... - October 18, 2022 - Huntington Study Group
Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group
SYNG Pharmaceuticals Announces Issuance of Its Canadian Patent for Non-Hormonal Therapy for Endometriosis
SYNG Pharmaceuticals Inc. (SYNG), a Kingston, Ontario based women’s health biotech, is pleased to announce that on October 04, 2022, the Canadian Intellectual Property Office granted Canada Patent No. 2,903,608 titled, "Treatment of endometriosis, angiogenesis and/or endometrial lesion growth." - October 09, 2022 - SYNG Pharmaceuticals Inc.
Zoo Media Debuts a Green Alternative to Plastic Bottles to Promote Zoos, Aquariums, and Fish Hatcheries
Zoo Media, the leading provider of smart advertising for zoos and aquariums in the U.S., is proud to introduce Pure Box Water: an earth-friendly, cardboard water container that supports maximum advertising of zoos, aquariums, and fish hatcheries and helps preserve America's land and wildlife. Dan... - September 30, 2022 - Zoo Media
Evidence Partners Rebrands as DistillerSR to Leverage Market Awareness of Its Core Literature Review Platform
The Company Also Bolstered Its Executive Team in Security, Product Management and Operations to Support Accelerating Growth - September 28, 2022 - DistillerSR
ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala
Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research. - September 28, 2022 - ALS Therapy Development Institute
New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report
800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC
Virb to Collaborate with Tufts CSDD on CRA Roundtable on October 18, 2022
Event to focus on the connection between CRA experience and performance. - September 20, 2022 - Virb
Zoo Media Debuts a Green Alternative to Plastic Bottles to Promote Zoos in America
Zoo Media is elated to introduce Pure Box Water, an earth-friendly, cardboard water container that allows for maximum zoo advertising while playing a leading role in preserving America's land and wildlife. Dan Kost, Chief Executive Officer of Zoo Media, said, "The clever promotion will allow... - September 08, 2022 - Zoo Media
Paras Biopharmaceuticals Finland Oy Has Been Identified as One of the "Fastest Growing Companies in the Nordic Biotechnology Therapeutics & Diagnostics Industry"
Paras Biopharmaceuticals is pleased to announce that the company has been identified as one of the Fastest Growing Companies in the Nordic Biotechnology Therapeutics and Diagnostics industry by Plimsoll Publishing UK. - September 01, 2022 - Paras Biopharmaceuticals Finland Oy
CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods
The Cayman Biomedical Research Institute (CABRI) is offering research grants in amounts up to $100,000 to support essential research on specialized pro-resolving mediator (SPM) analytical methods. - August 26, 2022 - Cayman Chemical Company
Deadline Extended: CABRI Announces Undergraduate Fellowships and Scholarship Program
The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until September 18, 2022. - August 26, 2022 - Cayman Chemical Company
Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances
Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions. - August 05, 2022 - Hemanext
Tim Wintz and Jarett Greenside Promoted to Senior Vice Presidents of Radiology for NY Imaging Specialists
NY Imaging Specialists announced today the appointments of Tim Wintz and Jarett Greenside to Senior Vice Presidents of Radiology. - August 02, 2022 - New York Imaging Specialists
ReproTech, LLC Welcomes New President & CEO, William Braun
ReproTech, LLC, the industry leader in human reproductive tissue cryogenic storage, is pleased to announce that William J. Braun has been selected as ReproTech’s new President and Chief Executive Officer. Braun assumed the role on April 4, 2022, and will be based in ReproTech’s Coconut Creek, FL location. - July 09, 2022 - ReproTech, LLC
Team Arnav Foundation to Hold 3rd Annual Event
Public announcement telling folks to participate in a local event whose proceeds help eradicate pediatric osteosarcoma. - July 09, 2022 - Team Arnav Foundation
River Valley Relief Names Ryan Kenaga President
River Valley Relief (RVR), a family-owned medical cannabis cultivator located in Fort Smith, Arkansas makes some organizational changes and names new President. - July 08, 2022 - River Valley Relief
Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology
Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa
Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East and Africa (EMEA). In his role,... - July 05, 2022 - Hemanext
Defined Bioscience Announces Formation of Scientific Advisory Board
Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.
HealthWare Systems Expands Services
HealthWare Systems meets evolving client needs with healthcare automation solutions, RPA, and services divisions – CredentialingOne & EligibilityAdvocates. - June 10, 2022 - HealthWare Systems
Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI
Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute
ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit
The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute
Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program
Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners
ASAcampus Involved Once Again in an Experiment That Will Take Place on the International Space Station
The experiment, selected by the European Space Agency in the ESA-ILSRA2014 call and with the support of the Italian Space Agency (C-ASI N. 2018-14-U.0-Suture in Space), aims to study the process of surgical wound healing in space. - May 22, 2022 - ASA srl